Eyckerman Lab — VIBUGent Center for Medical Biotechnology Ghent Belgium
Start date: as of 01/04/2026 Deadline to apply: 28 February 2026
VIB is a leading life sciences research institute in Belgium supported by the Flemish government and embedded within Flemish universities. VIB brings together 2000 scientists and staff in 10 research centres combining pioneering fundamental research with a strong drive to translate discoveries into applications in health biotechnology and agriculture. Researchers benefit from state-of-the-art core facilities (12 centralized platforms) and an experienced innovation & business team connecting science to industry and supporting spin-off creation.
Within VIB the Eyckerman lab creates and applies cutting-edge technologies to accelerate life sciences research within the Center for Medical Biotechnology and across VIB. Collaborating with biology-focused teams we uncover novel biology and open new avenues for therapeutic intervention. Initially focused on tools to study human protein complexes the lab has expanded to novel screening platforms in human cells for applications such as Deep Mutational Scanning and antibody specificity profiling.
Youll join a small team advancing a new screening platform focused on therapeutic antibody specificity. The aim is to deploy this newly developed assay for internal and external projects bringing it up to industry standards. You will
We are looking for candidates whose experience has prepared them to contribute to VIBs commitment to diversity and excellence.
Please direct inquiries about the position and suggestions of potential candidates to Applications must be submitted online via the VIB career portal ( before 28 February 2026. Please provide your CV 2 reference contacts and a motivation letter.